Role of HLA-DQ2 and HLA-DQ8 Genes in Coeliac Disease
4 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

A) Coeliac disease can result from a variety of genetic factors, one of which is HLA-DQ2 and HLA-DQ8 genes. Explain the role of these genes in the pathogenesis of coeliac disease, focusing on their association with gluten intolerance. (5 marks)

These genes encode proteins known as human leukocyte antigens (HLAs), which are responsible for presenting antigens to immune cells. In the context of coeliac disease, individuals who possess specific variants of the HLA-DQ2 (encoded by the HLA-DQA1 and HLA-DQB1 genes) and HLA-DQ8 (encoded by the HLA-DQA1 and HLA-DQB1 genes) genes are at an increased risk of developing the condition. These HLA molecules play a crucial role in initiating the immune response to gluten, the protein complex found in wheat, barley, and rye. Specifically, HLA-DQ2 and HLA-DQ8 molecules bind to gluten peptides that have been modified by tissue transglutaminase (tTG) within the gut lumen. This binding facilitates the presentation of gluten peptides to T lymphocytes, triggering an immune response characterized by inflammation and tissue damage within the small intestine.

Discuss the histological changes observed in the small intestine of individuals with coeliac disease and their significance in diagnosis. (5 marks)

These histological changes range from mild intraepithelial lymphocytosis ( an increase in the number of lymphocytes within the epithelial layer of the small intestine) to severe villous atrophy, reflecting the extent of damage to the intestinal mucosa caused by the autoimmune response to gluten. In coeliac disease, prolonged exposure to gluten triggers an immune-mediated attack on the intestinal mucosa, leading to damage and flattening of the villi. This results in a loss of surface area for nutrient absorption and can manifest as malabsorption-related symptoms such as diarrhea, weight loss, and nutrient deficiencies.

ompare the treatment options for coeliac disease, focusing on the effectiveness of a gluten-free diet and the management of associated nutrient deficiencies. (15 marks; 5 points for each stage)

Guide: Your answer should discuss the primary treatment approach for coeliac disease, including the role of a gluten-free diet in achieving histological recovery and normalizing nutrient levels. Additionally, address the potential persistence of nutrient deficiencies despite dietary changes and the recommended strategies for managing these deficiencies at different stages of life.

Treatment options for coeliac disease primarily revolve around the adoption of a strict gluten-free diet. However, effectively managing associated nutrient deficiencies is also crucial for optimizing the health and well-being of individuals with coeliac disease. adherence to a gluten-free diet is essential for promoting healing of the intestinal mucosa, can lead to histological recovery and resolution of symptoms and prevent further damage. nutrient supplementation in nutrients such as iron, calcium, vitamin D and B12 may be needed to resolve nutrient deficiencies. Regular monitoring of nutritional status and growth parameters is important for identifying and addressing any ongoing nutrient deficiencies or growth delays and for preventing long-term health complications such as osteoporosis and anemia. dults with coeliac disease are at increased risk of osteoporosis due to malabsorption of calcium and vitamin D. Therefore, emphasis should be placed on optimizing bone health through adequate calcium and vitamin D intake, regular weight-bearing exercise, and bone density monitoring.

What are the potential causes of diet-refractory coeliac disease, and how are they managed? (10 marks) Your answer should discuss the common causes of diet-refractory coeliac disease, such as non-malignant inflammation of the small intestine, enteropathy-associated T-cell lymphoma, collagenous sprue, and alternative diagnoses. For each cause, provide insights into the clinical presentation, diagnostic considerations, and management strategies.

<p>Non-Malignant Inflammation of the Small Intestine:clinical presentation: Persistent symptoms such as diarrhea, abdominal pain, and malabsorption despite adherence to a gluten-free diet. Diagnostic Considerations: Endoscopy with biopsy revealing ongoing inflammation and villous atrophy. Serological markers may remain elevated.</p> <p>Enteropathy-Associated T-Cell Lymphoma (EATL): Clinical Presentation: Severe symptoms, including weight loss, abdominal pain, and gastrointestinal bleeding. Lymphadenopathy may be present. Diagnostic Considerations: Biopsy showing infiltration of abnormal T-cells in the intestinal mucosa. Imaging studies may reveal lymphoma involvement.</p> <p>Collagenous Sprue: Clinical Presentation: Chronic diarrhea, weight loss, and malabsorption. Histological examination reveals subepithelial collagen deposition in the small intestine. Diagnostic Considerations: Endoscopic biopsy demonstrating collagenous thickening of the subepithelial layer. Alternative Diagnoses (Autoimmune Enteropathy, Common Variable Immunodeficiency, Drug-Induced Villous Atrophy): Clinical Presentation: Variable symptoms, including diarrhea, abdominal pain, and weight loss. History of autoimmune diseases or immunodeficiency may be present. Diagnostic Considerations: Comprehensive evaluation to rule out other causes of villous atrophy. Serological testing, imaging studies, and tissue biopsies may be necessary.</p> Signup and view all the answers

Study Notes

Coeliac Disease and Genetics

  • Coeliac disease is associated with genetic factors, including HLA-DQ2 and HLA-DQ8 genes.
  • These genes play a role in the pathogenesis of coeliac disease, specifically in the development of gluten intolerance.

Histological Changes in Coeliac Disease

  • Histological changes observed in the small intestine of individuals with coeliac disease include:
    • Villous atrophy (flattening of villi)
    • Crypt hyperplasia (increased crypt cell growth)
    • Increased intraepithelial lymphocyte count
  • These changes are significant in diagnosing coeliac disease.

Treatment Options for Coeliac Disease

  • Primary treatment approach: gluten-free diet
  • Goals of a gluten-free diet:
    • Achieve histological recovery
    • Normalize nutrient levels
  • Potential persistence of nutrient deficiencies despite dietary changes
  • Recommended strategies for managing nutrient deficiencies:
    • Supplemental vitamins and minerals
    • Regular monitoring of nutrient levels

Diet-Refractory Coeliac Disease

  • Causes of diet-refractory coeliac disease:
    • Non-malignant inflammation of the small intestine
    • Enteropathy-associated T-cell lymphoma
    • Collagenous sprue
    • Alternative diagnoses
  • For each cause:
    • Clinical presentation
    • Diagnostic considerations
    • Management strategies

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

Learn about the genetic factors contributing to coeliac disease, specifically the role of HLA-DQ2 and HLA-DQ8 genes in gluten intolerance. Understand how these genes affect the body's response to gluten. Test your knowledge of coeliac disease pathogenesis.

More Like This

Coeliac Disease Overview
171 questions
Coeliac Disease (CD) Quiz
102 questions
Use Quizgecko on...
Browser
Browser